Hypocalcemia in Covid-19: A Prognostic Marker for Severe Disease.

Autor: Raesi, Ahmad¹, Dezaki, Ebrahim Saedi², Moosapour, Hamideh³, Saeidifard, Farzane^4,5, Habibi, Zahra¹, Rahmani, Fereidoun⁶, Kheiri, Soleiman⁷, Taheri, Elham⁸ etpathology@gmail.com

Publikováno v: Iranian Journal of Pathology. Spring2021, Vol. 16 Issue 2, p144-153. 10p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Procalcitonin as a Prognostic Factor in Patients with COVID-19 in Southwestern Iran.

Autor: Abadi MSS; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.; Clinical Research Development Unit, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran., Taheri E; Molecular Pathology and Cytogenetic Ward, Pathology Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Raesi A; Department of Internal Medicine, Clinical Research Development Unit, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran., Arjmand MH; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.; Clinical Research Development Unit, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran., Kheirii S; Modeling in Health Research Center and School of Public Health, Department of Epidemiology and Biostatistics, Shahrekord University of Medical Sciences, Shahrekord, Iran., Shahinfard N; Clinical Research Development Unit, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran., Habibi Z; Clinical Research Development Unit, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Publikováno v: Infectious disorders drug targets [Infect Disord Drug Targets] 2022; Vol. 22 (3), pp. e070122200097.